A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
- Geens, W. (Speaker)
- Schwarze, J. K. (Contributor)
- Bertels, C. (Contributor)
- Tijtgat, J. (Contributor)
- Awada, G. (Contributor)
- F Vaeyens (Contributor)
- Louise Cras (Contributor)
- Vanbinst, A. (Contributor)
- Everaert, H. (Contributor)
- Michotte, A. (Contributor)
- Toon Janssen (Contributor)
- Ben Caljon (Contributor)
- Thomas Cauwenbergh (Contributor)
- Bruneau, M. (Contributor)
- Forsyth, R. (Contributor)
- Tuyaerts, S. (Contributor)
- Neyns, B. (Contributor)
- Duerinck, J. (Contributor)
- Clinical sciences
- https://lmmo.research.vub.be/en/home
- Faculty of Medicine and Pharmacy
- Neurosurgery
- Emergency Medicine
- Medical Oncology
- Supporting clinical sciences
- Radiology
- Medical Imaging
- Nuclear Medicine
- Basic (bio-) Medical Sciences
- Neuroprotection & Neuromodulation
- Pathology
- Neurology
- Surgical clinical sciences
- Experimental Pathology
Activity: Talk or presentation › Talk or presentation at a conference